0002-3115
Generic: galcanezumab-gnlm
Labeler: eli lilly and companyDrug Facts
Product Profile
Brand Name
Generic Name
galcanezumab-gnlm
Labeler
eli lilly and company
Dosage Form
INJECTION, SOLUTION
Active Ingredients
galcanezumab 100 mg/mL
Identifiers & Regulatory
Product NDC
0002-3115
Product ID
0002-3115_368df5d9-5eeb-49c7-a0dd-8a326ee5d78f
Product Type
DRUG FOR FURTHER PROCESSING
Marketing Category
DRUG FOR FURTHER PROCESSING
Listing Expiration
2026-12-31
Marketing Start
2019-06-04
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00023115
Hyphenated Format
0002-3115
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
emgality (source: label)
Generic Name
galcanezumab-gnlm (source: ndc)
Application Number
BLA761063 (source: label)
Routes
source: label
Resolved Composition
Strengths
- 100 mg/mL
Packaging
- 1 mL in 1 SYRINGE (0002-3115-00)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"spl_id": "368df5d9-5eeb-49c7-a0dd-8a326ee5d78f", "openfda": {}, "finished": false, "packaging": [{"description": "1 mL in 1 SYRINGE (0002-3115-00)", "package_ndc": "0002-3115-00", "marketing_start_date": "04-JUN-19"}], "product_id": "0002-3115_368df5d9-5eeb-49c7-a0dd-8a326ee5d78f", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "0002-3115", "generic_name": "galcanezumab-gnlm", "labeler_name": "Eli Lilly and Company", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "GALCANEZUMAB", "strength": "100 mg/mL"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_start_date": "20190604", "listing_expiration_date": "20261231"}